The filing is a routine Form 144 notice for a small share sale by an officer. No material impact on the stock is expected. Monitor for any subsequent Form 4 filings to confirm the sale was executed.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+1- T+0 · Nov 12 $122.71entry
- T+1 · 4d ago +0.19%α +0.55% · $122.94
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 24d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Maryanne Maunsell Farris, an officer of Haemonetics, filed a Form 144 notice of intent to sell 836 shares of common stock, with an estimated aggregate market value of approximately $101,144. The shares were acquired through restricted stock vesting and a stock option exercise. The sale is small relative to the company's $5.6B market cap and appears to be a routine insider transaction to cover tax obligations or diversify holdings.
Key Facts
- Officer Maryanne Maunsell Farris intends to sell 836 shares of Haemonetics common stock.
- Estimated aggregate market value of the sale is $101,144.38.
- Shares were acquired through restricted stock vesting on 05/15/2024, 05/15/2025, and 05/17/2025, and a stock option exercise on 11/11/2026.
- The sale is planned for on or after 11/12/2026 on the NYSE.
- The filing represents less than 0.002% of Haemonetics' outstanding shares based on the $5.6B market cap.
Financial Impact
Sale of 836 shares valued at ~$101,144, representing a negligible fraction of the company's $5.6B market cap.
Risk Factors
- Form 144 is an intent to sell; the actual sale may not occur.
- The filing does not disclose the officer's total holdings, so the proportional impact on her position is unknown.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001959173-26-007949 |
| Document: 0001959173-26-007949-index.html | 0001959173-26-007949 |
| Document: 0001959173-26-007949.txt | 0001959173-26-007949 |
Track record
14 reports on HAE
2 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +2.44% at T+5 after the Oct 20, 2026 report. 2 of 4 went positive at some point.
Filters
- Nov 12, 20264d ago 144 Neutral 2/10 Viewing Entry $122.71 Now $121.34 −1.12% settles Nov 19
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Bullish 5/10 Entry $124.11 to $122.71 Now $121.34 −2.23% ▼ −1.13% −4.42% vs SPY
- Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $117.11 to $119.97 Now $121.34 +3.61% ▲ +2.44% +2.89% vs SPY
- Oct 19, 202628d ago Press Release Bullish 7/10 Entry $118.21 to $119.97 Now $121.34 +2.65% ▲ +1.49% +1.41% vs SPY
- Oct 12, 20265w ago Institutional Cluster Bullish 4/10 Entry $122.06 to $118.73 Now $121.34 −0.59% ▼ −2.73% −1.23% vs SPY
- Oct 8, 20265w ago 8-K Neutral 4/10 Entry $119.47 to $121.29 Now $121.34 +1.57% ▲ +1.52% +1.80% vs SPY
- Sep 30, 20266w ago Press Release Neutral 1/10 Entry $104.37 to $119.47 Now $121.34 +16.26% ▲ +14.47% +13.17% vs SPY
- Sep 30, 20266w ago Court Ruling Neutral 3/10 Entry $104.37 to $119.47 Now $121.34 +16.26% ▲ +14.47% +13.17% vs SPY
- Aug 18, 202612w ago 8-K Neutral 3/10 Entry $104.65 to $108.32 Now $121.34 +15.95% ▲ +3.51% +3.71% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers